Wells Fargo’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-27
| Closed | -$81 | – | 7697 |
|
|
2024
Q1 | $81 | Buy |
27
+5
| +23% | +$23 | ﹤0.01% | 6714 |
|
|
2023
Q4 | $138 | Hold |
22
| – | – | ﹤0.01% | 6693 |
|
|
2023
Q3 | $476 | Buy |
22
+21
| +2,100% | +$548 | ﹤0.01% | 6370 |
|
|
2023
Q2 | $10 | Hold |
1
| – | – | ﹤0.01% | 7451 |
|
|
2023
Q1 | $23 | Buy |
+1
| New | +$109 | ﹤0.01% | 7334 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6911 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7620 |
|
|
2022
Q2 | – | Sell |
-1
| Closed | -$1.48K | – | 7732 |
|
|
2022
Q1 | $3K | Hold |
1
| – | – | ﹤0.01% | 6617 |
|
|
2021
Q4 | $3K | Hold |
1
| – | – | ﹤0.01% | 6838 |
|
|
2021
Q3 | $3K | Hold |
1
| – | – | ﹤0.01% | 6519 |
|
|
2021
Q2 | $7K | Buy |
+1
| New | +$6.46K | ﹤0.01% | 6251 |
|
|
2021
Q1 | – | Sell |
-32
| Closed | -$339K | – | 6557 |
|
|
2020
Q4 | $198K | Buy |
32
+12
| +60% | +$73.4K | ﹤0.01% | 5094 |
|
|
2020
Q3 | $139K | Sell |
20
-17
| -46% | -$126K | ﹤0.01% | 5128 |
|
|
2020
Q2 | $234K | Buy |
37
+27
| +270% | +$115K | ﹤0.01% | 4821 |
|
|
2020
Q1 | $33K | Buy |
10
+2
| +25% | +$8.31K | ﹤0.01% | 5478 |
|
|
2019
Q4 | $50K | Sell |
8
-2
| -20% | -$18.9K | ﹤0.01% | 5509 |
|
|
2019
Q3 | $131K | Buy |
10
+1
| +11% | +$8.03K | ﹤0.01% | 5194 |
|
|
2019
Q2 | $75K | Sell |
9
-5
| -36% | -$58.6K | ﹤0.01% | 5417 |
|
|
2019
Q1 | $183K | Hold |
14
| – | – | ﹤0.01% | 4871 |
|
|
2018
Q4 | $214K | Buy |
14
+8
| +133% | +$188K | ﹤0.01% | 4867 |
|
|
2018
Q3 | $222K | Sell |
6
-65
| -92% | -$2.14M | ﹤0.01% | 4951 |
|
|
2018
Q2 | $2.75M | Buy |
71
+70
| +7,000% | +$2.66M | ﹤0.01% | 3196 |
|
|
2018
Q1 | $19K | Buy |
+1
| New | +$26.9K | ﹤0.01% | 5820 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6098 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6121 |
|
|
2017
Q2 | – | Sell |
-2
| Closed | -$40.1K | – | 5934 |
|
|
2017
Q1 | $47K | Buy |
2
+1
| +100% | +$28.1K | ﹤0.01% | 5463 |
|
|
2016
Q4 | $16K | Hold |
1
| – | – | ﹤0.01% | 5684 |
|
|
2016
Q3 | $22K | Hold |
1
| – | – | ﹤0.01% | 5578 |
|
|
2016
Q2 | $24K | Hold |
1
| – | – | ﹤0.01% | 5456 |
|
|
2016
Q1 | $43K | Hold |
1
| – | – | ﹤0.01% | 5272 |
|
|
2015
Q4 | $35K | Buy |
+1
| New | +$53.9K | ﹤0.01% | 5416 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6513 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5923 |
|
|
2015
Q1 | – | Sell |
-1
| Closed | -$92.8K | – | 5823 |
|
|
2014
Q4 | $56K | Hold |
1
| – | – | ﹤0.01% | 4975 |
|
|
2014
Q3 | $48K | Buy |
+1
| New | +$93.1K | ﹤0.01% | 4955 |
|
Other funds holding TTOO
AC
TRCT
Wells Fargo's TTOO Position: Q2 2024 in Review
Wells Fargo sold out of T2 Biosystems, Inc (TTOO) in Q2 2024, closing a stake of 27 shares — an estimated $81 sold.
Wells Fargo first reported a position in TTOO in Q3 2014 and held it in 29 quarters. The position peaked at $2.75M in Q2 2018. 21 funds tracked by Wall St. Rank hold TTOO as of Q2 2024.
- Wells Fargo reported no remaining T2 Biosystems, Inc position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 27 T2 Biosystems, Inc shares in Q2 2024, an estimated $81.
- Wells Fargo first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 29 quarters.
- Wells Fargo's T2 Biosystems, Inc position peaked at $2.75M in Q2 2018.
- 21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.